Background-The involvement of Ca 2ϩ -dependent tyrosine kinase PYK2 in the Akt/endothelial NO synthase pathway remains to be determined. Methods and Results-Blood flow recovery and neovessel formation after hind-limb ischemia were impaired in PYK2 Ϫ/Ϫ mice with reduced mobilization of endothelial progenitors. Vascular endothelial growth factor (VEGF)-mediated cytoplasmic Ca 2ϩ mobilization and Ca 2ϩ -independent Akt activation were markedly decreased in the PYK2-deficient aortic endothelial cells, whereas the Ca 2ϩ -independent AMP-activated protein kinase/protein kinase-A pathway that phosphorylates endothelial NO synthase was not impaired. Acetylcholine-mediated aortic vasorelaxation and cGMP production were significantly decreased. Vascular endothelial growth factor-dependent migration, tube formation, and actin cytoskeletal reorganization associated with Rac1 activation were inhibited in PYK2-deficient endothelial cells. PI3-kinase is associated with vascular endothelial growth factor-induced PYK2/Src complex, and inhibition of Src blocked Akt activation. The vascular endothelial growth factor-mediated Src association with PLC␥1 and phosphorylation of 783 Tyr-PLC␥1 also were abolished by PYK2 deficiency. Conclusion-These findings demonstrate that PYK2 is closely involved in receptor-or ischemia-activated signaling events via Src/PLC␥1 and Src/PI3-kinase/Akt pathways, leading to endothelial NO synthase phosphorylation, and thus modulates endothelial NO synthase-mediated vasoactive function and angiogenic response.
identity to focal adhesion kinase. Tyrosine phosphorylation of PYK2 and focal adhesion kinase was triggered by integrin-mediated adhesion. 8 PYK2 was stimulated by a broad range of physiological stimuli such as stimuli for G-protein-coupled receptors that elevate intracellular Ca 2ϩ , 6, 7 phorbol ester, inflammatory cytokines, and stress signals, including ischemia. 9 PYK2 acts in concert with Src, which links Gi-or Gq-coupled receptors, leading to the MAP kinase pathway. 10 Furthermore, PYK2 binds to proteins that interact with the cytoskeleton, suggesting a role in the regulation of cellular morphology. The phenotype of PYK2-deficient mice was recently described as having macrophages that exhibit impaired migration as a result of cytoskeleton abnormality induced by diminished Ca 2ϩ mobilization and reduced activation of PI3-kinase. 11 In this study, we newly generated PYK2 Ϫ/Ϫ mice and investigated the molecular mechanism for the effects of PYK2 on NO-mediated vascular function and angiogenic response.
Methods

Statistical Analysis
Results are expressed as meanϮSEM. All data were transformed by the natural logarithm before ANOVA corresponding to each experiment. Repeated-measures ANOVA was used to analyze the time course experiment. The Scheffé test was used as the multiple comparison test. For comparisons between 2 groups, a 2-sample t test was performed. A value of PϽ 0.05 (2 tailed) was considered statistically significant.
Materials, construction of targeting vector, generation of PYK2 Ϫ/Ϫ mice ( Figure I of the online Data Supplement), Western blotting, immunohistochemistry, transfection of DNA plasmid, measurement of GTP-Rho and GTP-Rac, migration, tubular formation, in vivo angiogenesis, preparation of endothelial progenitor cell (EPC) -like cells, hind-limb ischemia, laser Doppler perfusion image, cGMP assay, measurement of NO metabolites and NO levels, acetylcholine (Ach)-and nitroprusside-mediated vasodilatation, measurement of cytoplasmic Ca 2ϩ concentration, fluorescence-activated cell sorting, and isolation of endothelial cells (ECs) from aorta and primary culture are described in the Methods section of the online Data Supplement. C57B1/6 strain mice (SHIMIZU Laboratory Supplies, Kyoto, Japan) were used. The animal experiments were approved by our institutional review board.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Impaired eNOS/Akt Activation and Ca 2؉ Mobilization by PYK2 Deficiency
eNOS was reported to be activated by VEGF, Ach, or ischemic stress. 12 Incubation of the aorta with VEGF (100 ng/mL) phosphorylates PYK2 time dependently with a peak level around 5 minutes ( Figure 1A ). Ach (1 mol/L) also caused PYK2 phosphorylation with a similar peak level, the extent of which was comparable to that in VEGF stimulation ( Figure 1A ). Ischemic stress time dependently increased the phosphorylation of PYK2 in the hind-limb muscle ( Figure  1B ). Such PYK2 phosphorylation was observed in the primary cultured aortic von Willebrand factor-positive ECs after stimulation with VEGF (100 ng/mL) and Ach (1 mol/L) and exposure to 1% hypoxia ( Figure 1C ). To clarify the cell types expressing PYK2, an immunohistochemical analysis was performed. Figure 1D showed that PYK2 was present mainly in the endothelial (CD31 ϩ ECs) and medial layers (vascular smooth muscle cells) in the aorta and in the CD31 ϩ vessels in the skeletal muscle, in which a few cells in the interstitial region (CD31 Ϫ ) also expressed PYK2.
We next examined whether the stimuli that induce PYK2 activation led to the phosphorylation of eNOS. Hind-limb ischemia causes eNOS phosphorylation in the skeletal muscle in wild-type (ϩ/ϩ) mice, whereas eNOS activation in the PYK2 Ϫ/Ϫ mice was markedly inhibited (Figure 2A ). Exposure of the aorta to VEGF or Ach also induced eNOS phosphorylation, whereas their activated levels were significantly diminished in the PYK2 Ϫ/Ϫ mice ( Figure 2B ). Induction of eNOS phosphorylation by VEGF or Ach or exposure to 1% hypoxia also was observed (2.3-to 2.5-fold, respectively; PϽ0.005) in the wild-type aortic ECs but strongly inhibited in the PYK2-deficient ECs ( Figure 2C ).
The ischemia-induced Akt phosphorylation in the skeletal muscle was significantly lower in the PYK2 Ϫ/Ϫ mice (46Ϯ3% at 2 hours, 34Ϯ3% decrease 1 day after ischemia; PϽ0.01) than the wild-type mice (Figure 2A ), whereas the tyrosine phosphorylation level in VEGF receptor-2 (Flk-1) did not significantly differ between the wild-type and PYK2deficient muscle (nϭ6 each; data not shown).
Akt phosphorylation in the aorta ( Figure 2B ) and ECs ( Figure 2C ) from the wild-type mice was significantly increased by VEGF stimulation (1.7Ϯ0.3-fold, PϽ0.05; and 3.0Ϯ0.7-fold, PϽ0.005, respectively), whereas Akt activation in the PYK2-deficient aorta and ECs was markedly attenuated (43Ϯ3% and 42Ϯ6% inhibition, respectively; PϽ0.05). Significant inhibition of Akt phosphorylation in ECs by PYK2 deficiency also was observed after exposure to 1% hypoxia (72Ϯ5% inhibition; PϽ0.01; Figure 2C ).
We examined the involvement of AMP-activated protein kinase (AMPK) 13 and cAMP-dependent protein kinase-A (PKA), 14 known as the Ca 2ϩ -independent kinase for phosphorylation of 1176 Ser-eNOS. The phosphorylation levels of AMPK and PKA after hind-limb ischemia did not differ significantly between PYK2 Ϫ/Ϫ and wild-type mice ( Figure  2A ). Furthermore, the phosphorylation of AMPK and PKA in PYK2-deficient ECs exposed to 1% hypoxia for 18 hours also was similar to the wild-type ECs (data not shown). Akt, AMPK, and PKA showed peak phosphorylation on day 1 and at 2 hours, respectively; PKA and AMPK then reversed to baseline levels on day 7, whereas moderate activation of Akt was observed on day 7 (220Ϯ30% increase compared with basal level; Figure 2A ). Neither AMPK nor PKA was activated 5 minutes after VEGF (100 ng/mL) treatment in both the wild-type and PYK2-deficient cells (data not shown), whereas dibutylic cAMP (1 mmol/L) and 5-aminoimidazole-4-carboxamide-1-␤-D-riboside AICAR (1 mmol/L) apparently phosphorylated PKA and AMPK in the wild-type ECs (positive controls; data not shown). These findings suggest that Akt, rather than Ca 2ϩ -independent AMPK or PKA, is involved in VEGF-mediated eNOS phosphorylation.
To prove that the reduced phosphorylation of eNOS is due directly to the loss of PYK2, we transfected GFP-tagged PYK2 plasmid to the PYK2-deficient ECs and studied by immunostaining with anti-phospho-1176 Ser-eNOS antibody whether VEGF-mediated phosphorylation of eNOS can be restored ( Figure 2D ). eNOS phosphorylation was observed in VEGF-exposed cells in which GFP-tagged PYK2 plasmid was transfected, whereas phospho-eNOS-positive cells were barely detected in the control GFP-transfected cells.
We next studied whether intracellular Ca 2ϩ mobilization was influenced by PYK2 deficiency. Figure 3A shows that VEGF-mediated elevation of cytoplasmic Ca 2ϩ levels was markedly inhibited in the PYK2-deficient ECs (Ca 2ϩ concentrations in PYK2 Ϫ/Ϫ , 95Ϯ24 nmol/L versus wild type, 432Ϯ69 nmol/L; PϽ0.001), whereas Ca 2ϩ mobilization with ATP that directly opens the Ca 2ϩ channel on the plasma membrane 15 was comparable to the wild type ( Figure 3A ), suggesting that the pathway for the receptor-independent Ca 2ϩ mobilization is not impaired. To study the effect of PYK2 deficiency on the other Ca 2ϩ signaling pathway not involving NO formation, we studied the activation of the Ca 2ϩ -dependent transcription factor nuclear factor of activated T cells 2 (NFATc2), which was shown to be crucial for VEGF-mediated angiogenesis. 16 The results showed that 68Ϯ8% of the wild-type cells showed nuclear translocation of NFATc2 from cytoplasm 30 minutes after VEGF stimulation, whereas in the PYK2-deficient cells, the translocation was markedly reduced (22Ϯ6%; PϽ0.01), indicating that PYK2 deficiency inhibits Ca 2ϩ signaling pathway not involving NO formation ( Figure 3B ). To prove that the functional effects are due directly to the loss of PYK2, we transfected the GFP-tagged PYK2 plasmid to the PYK2-deficient cells and observed VEGFmediated nuclear translocation of NFATc2. In the PYK2deficient cells transfected with GFP-tagged PYK2 plasmid, the number of NFATc2-translocated cells increased significantly (from 22Ϯ6% to 48Ϯ9%; PϽ0.05; Figure 3B ), whereas in the control GFP-transfected cells, the translocated cells did not increase significantly (data not shown). Pretreatment with a chelator of intracellular Ca 2ϩ store, AM-BAPTA (5 mol/L), in the Ca 2ϩ -free medium for 45 minutes did not affect VEGFinduced Akt activation in ECs ( Figure 3C ), indicating that Akt activation is Ca 2ϩ independent in our system.
Reduced Response by PYK2 Deficiency in NO Production and Ach-Mediated Vasodilatation
The intracellular NO level was measured with 4-amino-5methyl-amino-2Ј,7Ј-difluorofluorescein diacetate (DAF-FM DA). NO was visualized as green under laser Figure 1 . Activation of PYK2 by VEGF, Ach, and hind-limb ischemia. A, Aortic tissue removed from wild-type mice was incubated with the medium including VEGF (100 ng/mL) or Ach (1 mol/L) for 5 minutes. B, Time-dependent PYK2 phosphorylation in hind-limb muscles was examined after ligation of femoral artery. C, Left, Aortic ECs were stimulated with VEGF (100 ng/mL) or Ach (1 mol/L) for 5 minutes or exposure with 1% hypoxia for 18 hours. Tissue or cell lysates were subjected to immunoprecipitation with an anti-PYK2 antibody, followed by immunoblotting with anti-phosphotyrosine or anti-PYK2 antibodies. Data are meanϮSE (nϭ5 each); representative results are shown. Right, Cells were immunostained with anti-von Willebrand factor antibody to identify the ECs. D, Distribution of PYK2 in the aorta and limb muscle. Aorta and limb muscle were frozen-sectioned, fixed with acetone, and subjected to double immunostaining with antibodies against PYK2 (green) and CD31 (red). The merged cells (yellow) are indicated by arrowheads; PYK2-positive smooth muscle in the aorta, by arrows. I indicates intima; M, media. microscopy ( Figure 4A ). In the wild-type ECs, VEGF increased NO levels by 3.2-fold (PϽ0.005 versus untreated cells), whereas this increase was severely impaired in the PYK2-deficient ECs. NO metabolites in the 24-hour urine sample were significantly lower in the PYK2 Ϫ/Ϫ mice than the wild-type mice (4084Ϯ820 versus 9326Ϯ1163 nmol; PϽ0.005; Figure 4B ). Oral administration of N Gnitro-L-arginine methyl ester (L-NAME; 3 mmol/L in drinking water) to the wild-type mice reduced the NO metabolite production to a level comparable to the PYK2 Ϫ/Ϫ mice ( Figure 4B ).
Ach-mediated vasodilatation is induced by the eNOS-NO system. We next examined whether Achmediated relaxation of the aorta is influenced by PYK2 deficiency. The dose-dependent relaxation of the isolated aorta constricted by norepinephrine was evaluated ( Figure  4C ). Ach (10 mol/L) -mediated relaxation response was much weaker in the PYK2-deficient aorta than in the wild-type aorta (32Ϯ8% versus 59Ϯ5% relaxation; PϽ0.01), whereas norepinephrine (300 nmol/L) -mediated vasoconstriction in the PYK2-deficient aorta did not significantly differ from the wild-type aorta (190Ϯ30% versus 165Ϯ6% relative to 50 mmol/L KCl-mediated constriction; nϭ5). This result suggests that Ca 2ϩ signaling transmitted mainly through voltage-dependent Ca 2ϩ channel leading to the constriction of vascular smooth muscle cells is not impaired in the PYK2-deficient aorta.
To evaluate the NO dependency on Ach-mediated vasorelaxation, the effect of L-NAME was studied. Addition of L-NAME (10 mol/L) markedly suppressed the Achmediated maximum relaxation of the wild-type aorta (from 59Ϯ5% to 17Ϯ2%; PϽ0.001; nϭ4), whereas in the PYK2deficient aorta, the reduced relaxation response was suppressed further to a level comparable to L-NAME-treated . Impaired eNOS/Akt activation in PYK2-deficient mice. A, Skeletal muscle (nϭ10) was excised at the indicated time after ischemia. B, Aortic tissue (nϭ6 for each stimuli) was stimulated with VEGF (100 ng/mL) or Ach (1 mol/L) for 5 minutes. C, Aortic ECs (nϭ6 for each stimuli) were stimulated with VEGF (100 ng/mL) or Ach (1 mol/L) for 5 minutes or 1% hypoxia for 18 hours (nϭ6 each). Cell lysates were subjected to immunoprecipitation with anti-eNOS antibody, followed by immunoblot with antibodies against 1176 Serphosphorylated eNOS or eNOS. In addition, lysates were immunoblotted with antibodies against 473 Ser-phosphorylated Akt or Akt. Relative phosphorylation levels of eNOS and Akt are shown. Open circles and closed squares indicate the wild-type and PYK2 Ϫ/Ϫ mice, respectively. A, *PϽ0.05, **PϽ0.01 vs the same time points of the PYK2 Ϫ/Ϫ mice. B, C, *PϽ0.05, **PϽ0.005 vs the nonstimulated control. D, Aortic ECs were transfected with GFP-or GFP-PYK2-cDNA-plasmid. Forty-eight hours after transfection, cells were stimulated with VEGF (100 ng/mL), fixed with 4% paraformaldehyde, permeabilized with 0.02% Triton/PBS, and immunostained with antibodies against GFP-(red) or 1176 Ser-phosphorylated eNOS (green). Ratio of the GFP/p-eNOS double-positive cells (%) (yellow) to the total GFP-positive cells (red) was evaluated. *PϽ0.005; nϭ4.
wild-type aorta (from 32Ϯ8 to 18Ϯ3%; PϽ0.005; nϭ4). These findings indicate that Ach-mediated vasorelaxation depends mainly on NO production, in which an involvement of PYK2-mediated NO signaling was estimated to be Ϸ64% [(59Ϫ32/59Ϫ17)ϫ100] of the total NO-mediated vasodilation activated downstream of Ach. NO donor (nitroprusside) -induced vasorelaxation of the aorta was similar in both groups (82Ϯ4 versus 83Ϯ4%; nϭ5), suggesting that NOmediated signal transduction for vasodilatation is not impaired in the PYK2-deficient aorta ( Figure 4C ).
NO-mediated vasodilatation requires cGMP as a second messenger. We therefore measured the amount of cGMP in the aorta. Basal cGMP production in the PYK2 Ϫ/Ϫ mice was 41% lower than that in the wild-type mice. Ach increased aortic cGMP production 4.8-fold in the wildtype mice, whereas the increase in the PYK2 Ϫ/Ϫ mice was 2.0-fold, significantly (PϽ0.01) lower than in the wildtype mice ( Figure 4D ).
Decrease in Neovessel Formation by PYK2 Deficiency
Angiogenesis in the ischemic tissue requires eNOS activation. 17 We analyzed the blood flow recovery and neovessel formation after hind-limb ischemia. The ratio of blood flow recovery assessed by laser Doppler imaging was significantly lower in the PYK2 Ϫ/Ϫ mice than in the wild-type mice (50% versus 76% recovery at 3 weeks after ischemia; PϽ0.01; Figure 5A ). Oral administration of L-NAME (3 mmol/L in drinking water) significantly reduced the recovery ratio in the wild-type (from 76% to 62%; PϽ0.05) and PYK2 Ϫ/Ϫ (from 50% to 37%; PϽ0.05) mice ( Figure 5A ). Considering that the recovery ratio of the L-NAME-treated wild-type mice (62%) is close to that of the PYK2 Ϫ/Ϫ mice (50%), the blood flow recovery after hind-limb ischemia is considered to be regulated mainly by PYK2-mediated NO signaling. We also counted the number of CD31 ϩ vessels in the ischemic muscle. There was no significant difference in the basal vessel numbers surrounding the muscle fibers. The vessel number (per muscle fiber) in the wild-type mice increased 2.3-fold (PϽ0.005) after hind-limb ischemia, whereas the PYK2 Ϫ/Ϫ mice showed no significant increase ( Figure 5B ). We next examined whether PYK2 deficiency affects the mobilization or differentiation of EPCs. We found that 3 days after limb ischemia, the number of circulating CD45 Ϫ /Flk-1 ϩ EPCs was significantly lower (36%; PϽ0.05) in the PYK2 Ϫ/Ϫ mice than the wild-type mice (0.28Ϯ0.06% and 0.18Ϯ0.03% relative to total peripheral blood mononuclear cells, respectively; nϭ10 each; Figure 5C ). Considering that the mobilization of EPCs was reportedly regulated by the eNOS function of EPCs in a VEGF-dependent manner, 18 the present study suggests that PYK2 deficiency attenuates VEGFmediated EPC mobilization by impairing Ca 2ϩ /eNOS signaling.
Impaired cGMP-Dependent Protein Kinase-and eNOS-Mediated Migration of PYK2-Deficient ECs
NO-mediated angiogenesis depends on the migration of ECs, in which cGMP-dependent protein kinase (GK) or eNOS plays a crucial role. 19 Because it was reported that the migration of macrophages was severely impaired in PYK2 Ϫ/Ϫ mice, 11 the migration activity of aortic ECs was evaluated by the Boyden chamber assay. VEGF-mediated migration was 41% lower (PϽ0.01) in the PYK2-deficient ECs than wildtype ECs ( Figure 6A ). Pretreatment with L-NAME (3 mmol/L) or Rp-8-Br-cGMPS (1 mol/L, a GK inhibitor) markedly inhibited the VEGF-mediated migration activities of wild-type ECs (50% and 45% inhibition, respectively; Figure 6A ). L-Arginine (1 mmol/L) or GK activator 8-Bromo-cGMP (1 mol/L) treatment restored the reduced migration of PYK2-deficient ECs to the wild-type level, whereas L-NAME or GK inhibitor (1 mol/L) did not significantly affect their migration activities ( Figure 6A ).
The tubular formation activity and 3-dimensional angiogenesis in the Matrigel plug were significantly decreased in the PYK2-deficient ECs (59% and 38% decrease, respectively; Figure 6B and 6C). L-NAME diminished the tubular formation of wild-type ECs (39%; PϽ0.05), and L-arginine treatment improved the decreased activity of PYK2-deficient ECs (52%; PϽ0.01) ( Figure 6B ). These findings suggested that PYK2-mediated migration of ECs and angiogenic response are regulated mainly by NO and GK activation. Considering that GK affects the cytoskeleton structure, 20 PYK2 may modulate the cytoskeleton structure, leading to the regulation of cell migration and eventually angiogenesis. We therefore examined the effect of PYK2 on the F-actin structure of ECs. In the basal condition, we observed the stress fibers in 55Ϯ5% of the total wild-type ECs attaching on a fibronectin-coated dish and in 76Ϯ5% of PYK2deficient ECs (PϽ0.05) ( Figure 7A ). VEGF stimulation markedly decreased the number of stress fiber-positive wildtype cells (from 55Ϯ5% to 15Ϯ4%; PϽ0.01) and 64Ϯ6% of the total attaching wild-type cells exhibited the accumulation of F-actin at the plasma membrane, whereas in the PYK2deficient ECs, 72Ϯ8% of cells still had the apparent stress fibers and the cells showing the F-actin accumulation at the plasma membrane was only 23Ϯ3%. Pretreatment with L-NAME inhibited VEGF-mediated F-actin accumulation at the plasma membrane (PϽ0.01) and increased the stress fiber formation (PϽ0.05) in the wild-type cells, whereas the addition of L-arginine to PYK2-deficient ECs attenuated the stress fiber formation (PϽ0.01) and enhanced the VEGFmediated F-actin accumulation at the plasma membrane (PϽ0.05).
Because F-actin structure was regulated by Rho-family small GTPases, we evaluated the activities of RhoA and Rac1 by pull-down assay using GST-RBD 21 and GST-PBD, 22 respectively ( Figure 7B ). The amount of GTP-bound RhoA was decreased significantly in the wild-type ECs 5 minutes after VEGF treatment, whereas in the PYK2-deficient ECs, they were reduced more extensively than in the wild-type ECs. In contrast, the amount of GTP-bound Rac1 was increased markedly in the wild-type ECs, whereas its increase was abolished by the PYK2 deficiency. Considering that Rac1 plays a pivotal role in F-actin reorganization 23 and PYK2 promotes Rac-mediated JNK activation, 24 lack of VEGF-mediated Rac1 activation may be associated with the altered F-actin structure in the PYK2-deficient cells. Further- Figure 5 . Reduced recovery of blood flow and neovessel formation in the ischemic hind limb of PYK2 Ϫ/Ϫ mice. A, Reduced blood perfusion in ischemic limbs (green to blue) was observed in the PYK2 Ϫ/Ϫ mice in contrast with perfusion (red to yellow) in the wild-type mice. Computer-assisted analyses revealed significantly lower blood perfusion values in PYK2 Ϫ/Ϫ mice. Administration of L-NAME (3 mmol/L) in drinking water reduced the increased perfusion in both the wild-type and PYK2 Ϫ/Ϫ mice. Values shown are meanϮSE (nϭ8 each time point). *PϽ0.05, **PϽ0.01 vs wild-type mice; ***PϽ0.05 vs PYK2 Ϫ/Ϫ mice. B, Hind-limb muscles were removed 14 days after ischemia, and ECs were immunostained with an anti-CD31 antibody. The number of CD31 ϩ vessels surrounding the muscle fiber is shown. Data are meanϮSE (nϭ8 each). *PϽ0.005 vs ischemia (-) muscles; †PϽ0.005. C, Three days after hind-limb ischemia, peripheral blood was incubated with FITC-conjugated anti-CD45 and PE-conjugated anti-Flk-1 antibodies. Peripheral blood-derived mononuclear cells were analyzed by fluorescence-activated cell sorter after lysis of erythrocytes. The relative number of CD45 Ϫ /Flk-1 ϩ EPCs to total mononuclear cells was shown (nϭ10; *PϽ0.05). more, treatment with L-NAME attenuated VEGF-mediated Rac1 activation in the wild-type ECs, whereas addition of L-arginine to the PYK2-deficient ECs restored the response, indicating that PYK2-mediated Rac1 activation is NO dependent ( Figure 7B ).
Taniyama et al 25 showed that in the angiotensin IIstimulated cells (vascular smooth muscle cells), Ca 2ϩ -activated PYK2 acts as a scaffold for Src-dependent phosphorylation of 3-phosphoinositide-dependent protein kinase, the activator of Akt, whereas VEGF-induced Akt activation appears to be Ca 2ϩ independent ( Figure 3C ). We therefore evaluated the target of PYK2 in the VEGF-mediated signaling pathways leading to Akt activation or Ca 2ϩ mobilization. We found that VEGF stimulation causes PYK2 association with Src in the wild-type ECs, leading to the phosphorylation of Src ( Figure 7C ) and Akt (Figures 2B and 7C ). PYK2 deficiency significantly inhibited VEGF-mediated Src and Akt activation, and inhibition of Src activity by PP1 blocked Akt and PYK2 phosphorylation ( Figures 2B and 7C ). Immunoprecipitation experiments indicated that Src, but not PYK2, is closely associated with the p85 subunit of PI3K and that the Src/PI3K complex binds to PYK2 in response to VEGF (Figure 7C, bottom) .
To study PYK2-mediated Ca 2ϩ signaling after stimulation with VEGF, we studied PLC␥1 activation, known to cause an increase in Ca 2ϩ level. 26 We found that VEGF-mediated Src association with PLC␥1 and phosphorylation of 783 Tyr-PLC␥1 (both basal and VEGF induced) were significantly decreased in the PYK2-deficient cells and that the treatment with the Src inhibitor PP1 abolished VEGF-induced PLC␥1 phosphorylation ( Figure 7D ).
Taken together, it is likely that the direct target of PYK2 is Src and that Src-bound PI3-kinase and Src-bound PLC␥ are involved in activation of Akt and Ca 2ϩ mobilization, respectively.
Discussion
Tyrosine kinases have been assumed to be the upstream molecule for PI3K-Akt-eNOS or Ca 2ϩ -eNOS pathways. eNOS is activated by Akt, and intracellular Ca 2ϩ upregulates eNOS activity, raising the possibility that Ca 2ϩ -dependent tyrosine kinase PYK2 is a possible eNOS activator. This study provides the first evidence that (1) PYK2 deficiency attenuates VEGF-mediated eNOS phosphorylation associated with decreased Akt activation and intracellular Ca 2ϩ mobilization, (2) PYK2 is associated with the Src/PI3K complex and inhibition of Src blocked Akt phosphorylation, (3) Ach-mediated vasodilation of the aorta was diminished by decreased cGMP production in PYK2 Ϫ/Ϫ mice, and (4) PYK2 plays a central role in VEGF-or ischemia-mediated eNOS activation followed by angiogenic response in which VEGFinduced EPC mobilization, VEGF-dependent migration, actin cytoskeletal reorganization associated with reduced Rac1 activation were markedly inhibited in the PYK2-deficient ECs. Cell migration reportedly requires the recycled mobilization of actin from the old focal adhesion toward the plasma membrane of the leading edge to form the lamellipodia and new focal contact, 27 suggesting that impaired reorganization of the F-actin at the plasma membrane plausibly causes attenuated migration of the PYK2-deficient ECs. eNOS activation is dependent on an increase in [Ca 2ϩ ]i and the binding of Ca 2ϩ /calmodulin to the enzyme, leading to conformational change to displace the autoinhibitory loop. 28 If Ca 2ϩ mobilization is totally abolished, administration of the eNOS substrate arginine could not restore eNOS activity. However, VEGF-induced increase in [Ca 2ϩ ]i and subsequent translocation of NFATc2 in PYK2-deficient ECs remain Ϸ23% and Ϸ32%, respectively, of the wild-type cells ( Figure  3 ). This increase in [Ca 2ϩ ]i could cause the conformational change in eNOS, resulting in the recovery in eNOS activation after arginine administration.
The present study showed that PYK2 deficiency attenuates VEGF-mediated association of Src with PLC␥1 and phosphorylation of PLC␥1. VEGF was shown to stimulate the Figure 7 . Impaired reorganization of F-actin in PYK2-deficient cells. A, F-actin structure of ECs. ECs were cultured on the fibronectincoated glass chamber. After 16 hours of starvation (0.5% serum) with or without preincubation by L-arginine (1 mmol/L) or L-NAME (3 mmol/L), ECs were stimulated with VEGF (100 ng/mL) for 30 minutes, fixed with 4% paraformaldehyde, and permeabilized with 0.02% triton, and F-actin was stained with TRITC-labeled phalloidin. Representative staining was shown (nϭ7 each). Yellow arrows indicate the stress fiber; white arrows, accumulated F-actin at the plasma membrane. The cells with stress fiber or accumulated F-actin at the plasma membrane were counted, and the ratio (%) relative to total attaching cells was shown. *PϽ0.05, **PϽ0.01. B, Measurement of the VEGF-induced RhoA:GTP/Rac1:GTP. After 16 hours of starvation with or without L-NAME or L-arginine, ECs were incubated by VEGF for 5 minutes. Cell lysates were incubated with GST-RBD (Rho-binding domain) and GST-PBD (p21-binding domain) bound to glutathione beads as described in the Methods section of the online Data Supplement. The amount of RhoA:GTP and Rac1:GTP complex was determined by immunoblot with anti-RhoA and anti-Rac1 antibodies. *PϽ0.05, **PϽ0.01 (nϭ4 each) vs nonstimulated group. C, After 16 hours of starvation with or without PP1, ECs were incubated with VEGF for 5 minutes. Top, Cell lysates were subjected to Western blotting with antibodies against anti-416 Tyr-phosphorylated-Src or Src. Middle, Cell lysates of the wild-type ECs were analyzed by Western blotting with antibodies against Akt, 473 Ser-phosphorylated Akt, PYK2, and 402 Tyr-phosphorylated PYK2. Bottom, Cell lysates of the wild-type ECs were immunoprecipitated (IP), followed by Western blotting using antibodies against anti-PYK2, Src, and p85 subunit of PI3-kinase. *PϽ0.05, **PϽ0.005 (nϭ5 each experiment). D, After 16 hours of starvation with or without PP1, ECs were stimulated with VEGF for 5 minutes. Cell lysates were subjected to immunoblotting with antibodies against PLC␥1 or 783 Tyr-phosphorylated PLC␥1, plus immunoprecipitation with anti-Src antibody, followed by immunoblot with antibodies against PLC␥1, 783 Tyr-phosphorylated PLC␥1, or Src. *PϽ0.05, **PϽ0.005 (nϭ4 each) vs nonstimulated groups. #PϽ0.05 vs VEGF-stimulated wild-type ECs.
association of VEGF receptor-2 with Src, and subsequent Src activation was a requisite for VEGF-mediated PLC␥1 activation. 29 Taken together, it is conceivable that the lack of intracellular Ca 2ϩ mobilization in VEGF-stimulated PYK2deficient cells is due to the inhibition of Src-associated PLC␥ activation.
Src and PYK2 are mutually activated in a stepwise manner. Association of Src-SH2-domain with 402 Tyr-phosphorylated-PYK2 leads to conformational change in Src to release the internal autoinhibition, resulting in the upregulation of its activity. Conversely, activated Src phosphorylates 881 Tyr-PYK2, leading to the downstream Grb2/Ras/MAPK pathway. 10 In response to VEGF receptor-2 stimulation, Src binds toward the phosphorylated 1212 Tyr of VEGF receptor-2 with its SH2 domain, leading to Src activation. 30 In addition, VEGF promotes association of VEGF receptor-2 with integrin (␣V␤3) and transmits integrin-dependent cell biological responses. 31 Activation of integrin (␣V␤3) induces phosphorylation of 402 Tyr-PYK2 and its association with integrin ␤3. 32 Integrin-activated PYK2 is associated with Src 33 and involved in VEGF-mediated cell migration. 34 Furthermore, integrin (␣V␤5) plays a crucial role in angiogenesis, 35 and inhibition of integrin (␣V␤5) disrupted VEGF-mediated and Src-dependent angiogenesis. 36 Thus, PYK2/Src complex is likely to integrate integrin with the VEGF receptor-2 signaling system.
Fluid shear stress-mediated activation of eNOS is dependent on Ca 2ϩ mobilized through a mechanical stress-activated Ca 2ϩ channel on the plasma membrane, whereas a Ca 2ϩindependent system has been reported recently. Fleming et al 37 demonstrated that shear stress elicits Src-mediated phosphorylation of platelet EC adhesion molecule-1 (PECAM-1) at the cell-to-cell contact, which is crucial for subsequent activation of Akt and eNOS. Furthermore, Tzima et al 38 showed that PECAM-1 forms a mechanosensory complex with VEGF receptor-2, leading to activation of PI3-kinase. These findings suggest that VEGF receptor-2 is involved in Src/PECAM-1-mediated Akt/eNOS activation in Ca 2ϩindependent manner. Unlike PECAM-1, PYK2 is localized at the cell-to-extracellular-matrix contact region. 8, 33 VEGF promotes the association of VEGF receptor-2 with integrin and integrin-dependent cell biological responses. 31 Thus, the PYK2/Src complex transmits the VEGF signals in association with extracellular matrix/integrins, suggesting that the Ca 2ϩindependent Src/PECAM-1 system is unlikely to be involved in PYK2-mediated Src activation.
Because the blood flow recovery ratio in the ischemic limbs was increased Ϸ5-fold on day 7 compared with the day 0 control level ( Figure 5A ), hemodynamic shear stress also could be proportionally elevated in the newly formed vessels. Shear stress was shown to elicit the phosphorylation of 1177 Ser-eNOS by activating both Akt and PKA. 28 As shown in Figure 2A , Akt, AMPK, and PKA showed peak phosphorylation on day 1 and at 2 hours, respectively, and then PKA and AMPK reversed to the baseline level on day 7, whereas moderate activation of Akt was observed on day 7 (210% increase compared with the basal level), suggesting that Akt, rather than PKA and AMPK, is involved in the eNOS activation 7 days after limb ischemia. However, further studies are required to define the involvement of other kinases associated with flow shear stress.
Conclusions
This analysis of PYK2 Ϫ/Ϫ mice demonstrates the critical role of PYK2 in Akt/NO signals activated by vasoactive substances or ischemic stress that modulates the vascular tonus or angiogenesis. These findings indicate that PYK2 can operate as a modulator for extracellular versatile stimuli, leading to eNOS activation, and is closely involved in the receptor-or ischemia-activated NO signaling events and thus regulates the cytoskeleton structure, vasoreactive function, or angiogenic response.
